MENU
BMRN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
BioMarin Pharmaceutical (BMRN) Ownership - Who owns BioMarin Pharmaceutical?
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
770 Lindaro Street
Phone
+1 415 506-6700
Employees
3401
Web
https://www.biomarin.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
11.28B
P/E Ratio
26.62
Total Cash
1.14B
Projected Growth
0.40
Total Debt
602.71M
Revenue
2.85B
Risk (Beta)
0.26
Dividend Yield
N/A
Total Cash/Share
5.93
Total Debt/Equity
45.30
Revenue/Share
14.51 USD as % of share price
Fundamentals
BMRN
Capitalization
11.3B
P/E Ratio
26.62
Risk (Beta)
0.26
Dividend Yield
N/A
Total Cash
1.14B
Total Cash/Share
5.93
Total Debt
603M
Total Debt/Equity
45.30
Projected Growth (PEG Ratio)
0.40
Revenue/Share (as % of the share price)
14.51%
Revenue
2.85B
ROE
N/A
Book Value
5.66B
P/B Ratio
1.99
Cash Flow
N/A
Earnings
2.25
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
191K
Current Ratio
5.33
Current Revenue Per Employee
245826.64
Dividends Per Share - Security
N/A
EBITDA
651M
Float
N/A
Float - Current
N/A
Gross Income Margin
81.78
Revenue To Assets
6.17
Shares Held By Institutions
25.4B
Shares Outstanding - Current
192M
Total Liabilities
1.33B
Total Volume MTD
N/A
Value
-1
Gain YTD
-10.513
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of innovative pharmaceuticals for serious diseases & medical conditions
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
770 Lindaro Street
Phone
+1 415 506-6700
Employees
3401
Web
https://www.biomarin.com